NEW YORK, Aug 20- An experimental drug from Tekmira Pharmaceuticals Corp helped lab monkeys recover from the most deadly strain of Marburg virus, a close cousin of Ebola, even after symptoms appeared, scientists reported on Wednesday.» Read More
The number of women choosing to have preventive mastectomies has risen by almost 50 percent in recent years, and surveys show they are happy with the decision.
China has earned praise from international scientists for its handling of an outbreak of a deadly new bird flu, but a history of public health cover-ups means the Chinese public is harder to win over.
A strain of bird flu that has been found in humans for the first time in eastern China is not a cause for panic, the World Health Organization said on Monday, even as the number of people infected rose to 21, with six deaths.
CNBC's Jon Fortt speaks with Facebook founder & CEO Mark Zuckerberg and Apple Chairman Art Levinson about a new foundation to offer a $33 million prize for life science research. "We all think our society needs more heroes who are scientists, researchers and engineers," he says.
Japan has one of the world’s highest suicide rates. But last year the number of suicides fell below 30,000 for the first time in 15 years, thanks in part to community efforts. The CSM reports.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
The National Geographic Channel is preparing to beam tweets into space, in response to the "Wow! signal," a transmission received from space.
BGI, based in China, is the world’s largest genomics research institute, with 167 DNA sequencers producing the equivalent of 2,000 human genomes a day, the New York Times reports.
Scientists have discovered neural pathways that seem to correlate with the kinds of people who deal well with financial risk, but even the very definition of risk gets pulled apart by experts.
DSM Chairman and CEO Feike Sijbesma told CNBC he expects the Dutch chemicals firm to perform well in the second half of the year following strong second quarter results which saw a boost in net profit, while revenue fell just shy of the Reuters average forecast.